Shetzline Michael's Form 4 filing
Ironwood Pharmaceuticals Inc (IRWD) · filed May 25, 2022
- Accession no.
- 0001209191-22-031842
- Filed
- May 25, 2022
- Trade date
- May 23, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market sales total $121.7K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Shetzline MichaelCIK 0001808509 | Officer (CMO,SVP,Head-Res&Drug) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 23, 2022 | Class A Common Stock | SSaleDisposed | −3,130 | $11.50 | −$35,995 | 273,698 | Direct | |
| May 23, 2022 | Class A Common Stock | SSaleDisposed | −7,453 | $11.50 | −$85,709.5 | 266,245 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.